Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, July 26, 2003 9:17:46 PM
Heres a little info. on RIBI -
Ribi ImmunoChem Research, Inc. develops biopharmaceutical products that stimulate the immune system to generate natural agents and signals to prevent and treat human diseases. The company researches, develops, produces and markets these products some of which are under investigation by other companies for use as adjuvants. The company also manufactures clinical products and develops processes for the commercial scale production of its compounds. The company's technology is based on potent capacities of certain microbial products to modulate the cytokine cascade in man and other animals. The product development of the company is the use of MPL immunomodulator in combination with other immunomodulator. The company's product, human biopharmaceutical is being regulated by the FDA, which requires to be tested for the use of human treatment. The company has 20 research products to date. The company has been using its research products to develop immunotherapeutic agents for the treatment of malignant tumors and other diseases. The company has spent approximately $237,000 towards year 2000 expenses. Contracts & licences accounted for 53% of 1998 revenues & biopharmaceutical products, 47%.
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM